Cambridge Financial Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.2M | Sell |
52,946
-2,005
| -4% | -$432K | 4.18% | 3 |
|
|
2025
Q4 | $11.3M | Buy |
54,951
+260
| +0.5% | +$48.9K | 4.31% | 3 |
|
|
2025
Q3 | $8.58M | Sell |
54,691
-1,874
| -3% | -$289K | 3.33% | 15 |
|
|
2025
Q2 | $9.5M | Sell |
56,565
-18,846
| -25% | -$2.8M | 4.79% | 3 |
|
|
2025
Q1 | $10.4M | Sell |
75,411
-1,955
| -3% | -$249K | 4.51% | 2 |
|
|
2024
Q4 | $9.15M | Buy |
+77,366
| New | +$9.03M | 3.78% | 5 |
|
|
2024
Q2 | $7.14M | Buy |
72,626
+425
| +0.6% | +$43.3K | 3.21% | 15 |
|
|
2024
Q1 | $8.08M | Sell |
72,201
-5,345
| -7% | -$577K | 3.58% | 9 |
|
|
2023
Q4 | $7.82M | Sell |
77,546
-8,106
| -9% | -$804K | 3.91% | 3 |
|
|
2023
Q3 | $7.44M | Buy |
+85,652
| New | +$7.74M | 4.05% | 5 |
|
|
2022
Q4 | $7.21M | Sell |
93,746
-30,695
| -25% | -$2.33M | 4.02% | 5 |
|
|
2022
Q3 | $8.3M | Buy |
+124,441
| New | +$7.89M | 4.99% | 1 |
|
|
2022
Q1 | $7.34M | Sell |
129,529
-7,885
| -6% | -$422K | 3.29% | 16 |
|
|
2021
Q4 | $7.08M | Buy |
137,414
+21,375
| +18% | +$1.05M | 2.78% | 24 |
|
|
2021
Q3 | $5.74M | Sell |
116,039
-2,589
| -2% | -$140K | 2.52% | 30 |
|
|
2021
Q2 | $6.77M | Sell |
118,628
-3,869
| -3% | -$226K | 2.9% | 28 |
|
|
2021
Q1 | $7.44M | Buy |
122,497
+645
| +0.5% | +$35.6K | 3.28% | 15 |
|
|
2020
Q4 | $6.53M | Buy |
121,852
+13,740
| +13% | +$713K | 3.1% | 22 |
|
|
2020
Q3 | $5.08M | Sell |
108,112
-3,145
| -3% | -$161K | 2.67% | 27 |
|
|
2020
Q2 | $5.81M | Sell |
111,257
-1,855
| -2% | -$95.6K | 3.27% | 18 |
|
|
2020
Q1 | $5.42M | Buy |
113,112
+2,770
| +3% | +$144K | 3.66% | 9 |
|
|
2019
Q4 | $5.58M | Sell |
110,342
-3,075
| -3% | -$159K | 2.84% | 26 |
|
|
2019
Q3 | $5.35M | Sell |
113,417
-3,610
| -3% | -$165K | 2.91% | 26 |
|
|
2019
Q2 | $5.51M | Buy |
117,027
+1,415
| +1% | +$65.3K | 2.93% | 26 |
|
|
2019
Q1 | $5.57M | Buy |
115,612
+16,310
| +16% | +$817K | 3.02% | 26 |
|
|
2018
Q4 | $4.43M | Buy |
99,302
+2,851
| +3% | +$149K | 2.83% | 21 |
|
|
2018
Q3 | $5.21M | Hold |
96,451
| – | – | 2.36% | 29 |
|
|
2018
Q2 | $4.71M | Buy |
96,451
+8,381
| +10% | +$475K | 2.32% | 30 |
|
|
2018
Q1 | $5.52M | Buy |
88,070
+1,049
| +1% | +$72K | 2.98% | 24 |
|
|
2017
Q4 | $5.33M | Buy |
87,021
+14,335
| +20% | +$886K | 2.63% | 29 |
|
|
2017
Q3 | $4.86M | Buy |
72,686
+1,251
| +2% | +$88.4K | 2.54% | 30 |
|
|
2017
Q2 | $5.57M | Sell |
71,435
-1,321
| -2% | -$99.7K | 2.98% | 22 |
|
|
2017
Q1 | $5.93M | Buy |
72,756
+4,072
| +6% | +$321K | 3.35% | 17 |
|
|
2016
Q4 | $4.94M | Buy |
68,684
+8,627
| +14% | +$624K | 2.88% | 26 |
|
|
2016
Q3 | $4.67M | Sell |
60,057
-362
| -0.6% | -$29.3K | 2.87% | 25 |
|
|
2016
Q2 | $4.71M | Sell |
60,419
-1,466
| -2% | -$117K | 2.88% | 25 |
|
|
2016
Q1 | $5.07M | Sell |
61,885
-10,236
| -14% | -$832K | 3.15% | 19 |
|
|
2015
Q4 | $6.44M | Sell |
72,121
-1,819
| -2% | -$154K | 3.85% | 4 |
|
|
2015
Q3 | $5.68M | Sell |
73,940
-2,388
| -3% | -$200K | 3.4% | 16 |
|
|
2015
Q2 | $6.38M | Sell |
76,328
-7,758
| -9% | -$685K | 3.4% | 14 |
|
|
2015
Q1 | $7.59M | Buy |
84,086
+75,009
| +826% | +$6.46M | 3.76% | 5 |
|
|
2014
Q4 | $733K | Sell |
9,077
-86,353
| -90% | -$6.82M | 3.56% | 7 |
|
|
2014
Q3 | $7.15M | Sell |
95,430
-2,541
| -3% | -$185K | 3.57% | 11 |
|
|
2014
Q2 | $6.72M | Sell |
97,971
-1,804
| -2% | -$123K | 3.34% | 13 |
|
|
2014
Q1 | $6.98M | Sell |
99,775
-13,328
| -12% | -$927K | 3.55% | 9 |
|
|
2013
Q4 | $7.56M | Sell |
113,103
-7,842
| -6% | -$479K | 3.85% | 3 |
|
|
2013
Q3 | $6.31M | Sell |
120,945
-9,134
| -7% | -$464K | 3.48% | 10 |
|
|
2013
Q2 | $6.52M | Buy |
+130,079
| New | +$5.94M | 3.28% | 18 |
|
Other funds holding CAH
VCM
VPM
Cambridge Financial Group's CAH Position: Q1 2026 in Review
Cambridge Financial Group reduced its Cardinal Health (CAH) stake by 3.6% in Q1 2026, selling an estimated $432K and leaving 52,946 shares worth $11.2M. The position accounts for 4.18% of the portfolio, ranked #3.
Cambridge Financial Group first reported a position in CAH in Q2 2013 and has held it in 48 quarters since. The position peaked at $11.3M in Q4 2025. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Cambridge Financial Group held 52,946 shares of Cardinal Health worth $11.2M as of Q1 2026.
- Cambridge Financial Group sold 2,005 Cardinal Health shares in Q1 2026, an estimated $432K.
- Cardinal Health made up 4.18% of Cambridge Financial Group's portfolio in Q1 2026, its #3 holding.
- Cambridge Financial Group first reported a position in Cardinal Health in Q2 2013 and has held it in 48 quarters since.
- Cambridge Financial Group's Cardinal Health position peaked at $11.3M in Q4 2025.
- 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Cambridge Financial Group's 13F filing for Q1 2026, filed 14 May 2026.